Angiodynamics (ANGO) Invested Capital (2011 - 2026)

Angiodynamics has reported Invested Capital for 16 years, with the latest figure at $173.4 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 9.18% year-over-year to $173.4 million; the trailing twelve-month figure through Feb 2026 stood at $173.4 million (down 9.18% YoY), and the FY2025 full-year result was $183.0 million, down 11.0% from the prior year.
• Invested Capital for Q1 2026 stood at $173.4 million, down from $176.3 million in the prior quarter.
• The five-year high for Invested Capital was $449.5 million in Q2 2022, with the low at $173.4 million in Q1 2026.
• Historically, Invested Capital has averaged $301.6 million across 5 years, with a median of $228.2 million in 2024.
• Annual changes were most pronounced in 2022 — Invested Capital climbed 2.28% — and 2024, when it slumped 53.44%.
• Angiodynamics' Invested Capital stood at $417.7 million in 2022, then declined by 1.7% to $410.6 million in 2023, then sank by 53.31% to $191.7 million in 2024, then retreated by 8.03% to $176.3 million in 2025, then slipped by 1.69% to $173.4 million in 2026.
• The last three Invested Capital figures came in at $173.4 million (Q1 2026), $176.3 million (Q4 2025), and $178.9 million (Q3 2025), per Business Quant data.